Rad Partners' Nina Kottler, MD, explains what practices should consider when assessing artificial intelligence solutions in an era where there is little reimbursement.  
 

The newly approved system was designed to assist clinicians with the detection of Alzheimer's disease and other forms of dementia.

However, GPT-4 confidently delivered incorrect or irrelevant answers on some questions, according to new research in Radiology. 

Radiologist David Gruen, MD, discusses some of the overarching themes from the Healthcare Information Management Systems Society's annual meeting.

Amit Trivedi, HIMSS director of informatics and health IT standards, explains the remaining gaps in interoperability and how it remains a moving target.

When tested, the model achieved a performance comparable to that of human experts.

Radiology makes up the vast majority of FDA-cleared AI algorithms, but with minimal or no reimbursement, hospital administrators may ask whether AI’s value justifies its expense.

The FDA-approved tool works by reprioritizing CTPA exams to the top of a radiologist’s work list when the scan is positive for PE.